Advertisement

Radiotherapy in Early Stage Non-Small Cell Lung Cancer

  • Branislav Jeremić
Part of the Medical Radiology Radiation Oncology book series (MEDRAD)

Keywords

Radiat Oncol Biol Phys Radiation Therapy Oncology Group Elective Nodal Irradiation Hyperfractionated Radiation Therapy Stereotactic Fractionate Radiation Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alexander E 3rd, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, Kooy HM, Loeffler JS (1995) Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87:34–40PubMedGoogle Scholar
  2. Armstrong JG, Burman C, Leibel S, Fontenla D, Kutcher G, Zelefsky M, Fuks Z (1993) Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 26:685–689PubMedGoogle Scholar
  3. Au J, el-Oakley R, Cameron EW (1994) Pneumonectomy for bronchiogenic carcinoma in the elderly. Eur J Cardiothorac Surg 8:247–250CrossRefPubMedGoogle Scholar
  4. Ball D, Bishop J, Smith J, O'Brien P, Davis S, Ryan G, Olver I, Toner G, Walker Q, Joseph D (1999) A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. Radiother Oncol. 52:129–136CrossRefPubMedGoogle Scholar
  5. Ball DL, Peters LJ, Smith J (2001) Untitled (letter to the editor). Radiother Oncol 58:89–90CrossRefPubMedGoogle Scholar
  6. Bahri S, Flickinger JC, Kalend AM, Deutsch M, Belani CP, Sciurba FC, Luketich JD, Greenberger JS (1999) Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams. Radiat Oncol Invest 7:297–308CrossRefGoogle Scholar
  7. Belderbos JSA, de Jaeger K, Heemsbergen WD, Seppenwoolde Y, Baas P, Boersma LJ, Lebesque JV (2003) First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol 66:119–126CrossRefPubMedGoogle Scholar
  8. Bentzen SM, Saunders MI, Dische S (2000) Updated data for CHART in NSCLC: further analyses. Radiother Oncol 55:86–87CrossRefGoogle Scholar
  9. Black WC, Armstrong P, Daniel TM (1988) Cost effectiveness of chest CT in T1N0M0 lung cancer. Radiology 167:373–378PubMedGoogle Scholar
  10. Blomgren H, Lax I, Naslund I, Svanstrom R (1995) Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34:861–870PubMedGoogle Scholar
  11. Bradley JD, Wahab S, Lockett MA, Perez CA, Purdy JA (2003) Elective nodal failures are uncommon in medically inoperable patients with stage I non-small-cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys 56:342–347CrossRefPubMedGoogle Scholar
  12. Braun SR, doPico GA, Olson CE, Caldwell W (1975) Low-dose radiation pneumonitis. Cancer 35:1322–1324PubMedGoogle Scholar
  13. Burman C, Kutcher GJ, Emami B, Goitein M (1991) Fitting of normal tissue tolerance data to analytic function. Int J Radiat Oncol Biol Phys 21:123–135PubMedGoogle Scholar
  14. Byhardt RW, Pajak TF, Emami B, Herskovic A, Doggett RS, Olsen LA (1993) A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07. Int J Radiat Oncol Biol Phys 26:459–468PubMedGoogle Scholar
  15. Chen M, Jiang G-L, Fu X-L, Wang LJ, Qian H, Chen GY, Zhao S, Liu TF (2000) The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer. Lung Cancer 28:11–19CrossRefPubMedGoogle Scholar
  16. Chen ZL, Perez S, Holmes EC, Wang HJ, Coulson WF, Wen DR, Cochran AJ (1993) Frequency and distribution of occult micrometastasis in lymph nodes of patients with non-small cell lung carcinoma. J Natl Cancer Inst 85:493–498PubMedGoogle Scholar
  17. Cheung PC, Mackillop WJ, Dixon P, Brundage MD, Youssef YM, Zhou S (2000) Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48:703–710PubMedGoogle Scholar
  18. Conces DJ, Jr., Klink JF, Tarver RD, Moak GD (1989) T1N0M0 lung cancer: evaluation with CT. Radiology 170:643–646PubMedGoogle Scholar
  19. Cooper JFD, Pearson FG, Todd TRJ (1985) Radiotherapy alone for patients with operable carcinoma of the lung. Chest 87:289–292PubMedGoogle Scholar
  20. Cox JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Pajak TF (1990) A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 to 79.2 Gy-possible survival benefit with > 69.6 Gy in favorable patients with Radiation Therapy Oncology group stage III nonsmall cell lung carcinoma. Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 8:1543–1555PubMedGoogle Scholar
  21. Cox JD, Pajak TF, Asbell S, Russell AH, Pederson J, Byhardt RW, Emami B, Roach M 3rd (1993) Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys 27:493–498PubMedGoogle Scholar
  22. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for the Treatment and Research of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346CrossRefPubMedGoogle Scholar
  23. Coy P, Kennelly GM (1980) The role of curative radiotherapy in the treatment of lung cancer. Cancer 45:698–702PubMedGoogle Scholar
  24. Dobashi K, Sugio K, Osaki T, Oka T, Yasumoto K (1997) Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance. J Thorac Cardiovsc Surg 114:339–346CrossRefGoogle Scholar
  25. Dosoretz DE, Katin MJ, Blitzer PH, Rubenstein JH, Salenius S, Rashid M, Dosani RA, Mestas G, Siegel AD, Chadha TT (1992) Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 25:3–9Google Scholar
  26. Dosoretz DE, Galmarini D, Rubenstein JH, Katin MJ, Blitzer PH, Salenius SA, Dosani RA, Rashid M, Mestas G, Hannan SE (1993) Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumour eradication. Int J Radiat Oncol Biol Phys 27:507–516PubMedGoogle Scholar
  27. Drzymala RE, Mohan R, Brewster L, Chu J, Goitein M, Harms W, Urie M (1991) Dose-volume histograms. Int J Radiat Oncol Biol Phys 21:71–78PubMedGoogle Scholar
  28. Dunbar SF, Tarbell NJ, Kooy HM, Alexander E 3rd, Black PM, Barnes PD, Goumnerova L, Scott RM, Pomeroy SL, La Vally B (1994) Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report. Int J Radiat Oncol Biol Phys 30:531–539PubMedGoogle Scholar
  29. Farrell MA, McAdams HP, Herndon JE, Patz EF Jr (2000) Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology 215:886–890PubMedGoogle Scholar
  30. Firat S, Bousamra M, Gore E, Byhardt RW (2002) Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52:1047–1057CrossRefPubMedGoogle Scholar
  31. Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, Hudgins WR, Weiner R, Harsh GR 4th, Sneed PK (1994) A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28:797–802PubMedGoogle Scholar
  32. Fontanini G, Macchiarini P, Pepe S, Ruggiero A, Hardin M, Bigini D, Vignati S, Pingitore R, Angeletti CA (1992) The expression of proliferative cell nuclear antigen in paraffin section of peripheral node-negative non-small cell lung cancer. Cancer 70:1520–1527PubMedGoogle Scholar
  33. Fukumoto S, Shirato H, Shimizu S, Ogura S, Onimaru R, Kitamura K, Yamazaki K, Miyasaka K, Nishimura M, Dosaka-Akita H (2002) Small-volume image-guided radiotherapy using hypofractionated coplanar and noncoplanar multiple fields with inoperable stage I nonsmall cell lung carcinomas. Cancer 95:1546–1553PubMedGoogle Scholar
  34. Furuta M, Hayakawa K, Katano S, Saito Y, Nakayama Y, Takahashi T, Imai R, Ebara T, Mitsuhashi N, Niibe H (1996) Radiation therapy for stage I-II non-small cell lung cancer in patients aged 75 years and older. Jpn J Clin Oncol 26:95–98PubMedGoogle Scholar
  35. Garipagaoglu M, Munley MT, Hollis D, Poulson JM, Bentel GC, Sibley G, Anscher MS, Fan M, Jaszczak RJ, Coleman RE, Marks LB (1999) The effect of patient specific factors on radiation induced regional lung injury. Int J Radiat Oncol Biol Phys 45:3331–3338CrossRefGoogle Scholar
  36. Gauden S, Tripcony L (2001) The curative treatment by radiation therapy alone of stage I non-small cell lung cancer in a geriatric population. Lung Cancer 32:71–79CrossRefPubMedGoogle Scholar
  37. Gauden S, Ramsay J, Tripcony L (1995) The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 108:1278–1282PubMedGoogle Scholar
  38. Ginsberg RJ, Rubinstein L (for the Lung Cancer Study Group) (1995) A randomised study of lobectomy versus limited resection for patients with T1 N0 non-small cell lung cancer. Ann Thorac Surg 60:908–913CrossRefPubMedGoogle Scholar
  39. Glazer GM, Orringer MB, Gross BH, Quint LE (1984) The mediastinum in non-small cell lung cancer. Am J Roentgenol 142:1101–1105Google Scholar
  40. Graham MV, Matthews JW, Harms WB, Emami B, Glazer HS, Purdy JA (1994) Three-dimensional radiation treatment planning study for patients with carcinoma of the lung. Int J Radiat Oncol Biol Phys 29:1105–1117PubMedGoogle Scholar
  41. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, Perez CA (1999) Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45:323–329CrossRefPubMedGoogle Scholar
  42. Graham PH, Gebski VJ, Langlands AO (1995) Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 31:261–266CrossRefPubMedGoogle Scholar
  43. Haffty BG, Goldberg NB, Gerstley J, Fischer DB, Peschel RE (1988) Results of radical radiation therapy in clinical Stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 15:69–73PubMedGoogle Scholar
  44. Hara R, Itami J, Kondo T, Aruga T, Abe Y, Ito M, Fuse M, Shinohara D, Nagaoka T, Kobiki T (2002) Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol 63:159–163CrossRefPubMedGoogle Scholar
  45. Hayakawa K, Mitsuhashi N, Nakajima N (1992) Radiation therapy for stage III epidermoid carcinoma of the lung. Lung Cancer 8:213–224CrossRefGoogle Scholar
  46. Hayakawa K, Mitsuhashi N, Saito Y, Nakayama Y, Furuta M, Sakurai H, Kawashima M, Ohno T, Nasu S, Niibe H (1999) Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 26:137–142CrossRefPubMedGoogle Scholar
  47. Hayakawa K, Mitsuhashi N, Katano S, Saito Y, Nakayama Y, Sakurai H, Akimoto T, Hasegawa M, Yamakawa M, Niibe H (2001) High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer 32:81–88CrossRefPubMedGoogle Scholar
  48. Hayman JA, Martel MK, Ten Haken RK, Normolle DP, Todd RF 3rd, Littles JF, Sullivan MA, Possert PW, Turrisi AT, Lichter AS (2001) Dose-escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy. Update of a phase I trial. J Clin Oncol 19:127–136PubMedGoogle Scholar
  49. Heavey LR, Glazer GM, Gross BH, Francis IR, Orringer MB (1986) The role of CT in staging radiographic T1N0M0 lung cancer. Am J Roentgenol 146:285–290Google Scholar
  50. Henschke CI, Wisnivesky JP, Yankelevitz DF, Miettinen OS (2003) Small stage I cancers of the lung: genuineness and curability. Lung Cancer 39:327–330CrossRefPubMedGoogle Scholar
  51. Hof H, Herfarth K, Munter M, Hoess A, Motsch J, Wannenmacher M, Debus J (2003) Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 56:3345–3341CrossRefGoogle Scholar
  52. Holsti LB, Vuorinen P (1967) Radiation reaction in the lung after continuous and split-course megavoltage radiotherapy of bronchial carcinoma. Br J Radiol 40:280–284PubMedGoogle Scholar
  53. Ishida T, Yano T, Maeda K (1991) Strategy for lymphadenopathy in lung cancer 3 cm or less in diameter. Ann Thorac Surg 50:708–771Google Scholar
  54. Jeremic B, Shibamoto Y, Acimovic LJ, Milisavljevic S (1997) Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 38:521–525CrossRefPubMedGoogle Scholar
  55. Jeremic B, Shibamoto Y, Acimovic LJ, Milisavljevic S (1999) Hyperfractionated radiotherapy for clinical stage II nons-mall cell lung cancer. Radiother Oncol 51:141–145CrossRefPubMedGoogle Scholar
  56. Jeremic B, Shibamoto Y, Acimovic LJ, Nikolic N, Dagovic A, Aleksandrovic J, Radosavljevic-Asic G (2001) Second cancers occurring in patients with early stage non-small cell lung cancer treated with chest radiation therapy alone. J Clin Oncol 19:1056–1063PubMedGoogle Scholar
  57. Jeremic B, Classen J, Bamberg M (2002) Radiation therapy alone in technically operable, medically inoperable early stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 5:119–130CrossRefGoogle Scholar
  58. Jeremic B, Classen J, Bamberg M (2003a) Re.: Observationonly management of early stage, medically inoperable lung cancer. Do not do that-a loud and a clear radiotherapeutic point of view! Chest 123:313–314CrossRefGoogle Scholar
  59. Jeremic B, Shibamoto Y, Milicic B, Dagovic A, Nikolic N, Aleksandrovic J, Acimovic L, Milisavljevic S (2003b) Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy (Hfx RT) alone. Lung Cancer 40:317–323PubMedGoogle Scholar
  60. Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C (1993) Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27:517–523PubMedGoogle Scholar
  61. Koike T, Terashima M, Takizawa T, Watanabe T, Kurita Y, Yokoyama A (1998) Clinical analysis of small-sized peripheral lung cancer. J Thorac Cardiovasc Surg 115:1015–1020PubMedGoogle Scholar
  62. Komaki R, Scott C, Ettinger D, Lee JS, Fossella FV, Curran W, Evans RF, Rubin P, Byhardt RW (1997) Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04. Int J Radiat Oncol Biol Phys 38:149–155CrossRefPubMedGoogle Scholar
  63. Kooy HM, Dunbar SF, Tarbell NJ, Mannarino E, Ferarro N, Shusterman S, Bellerive M, Finn L, McDonough CV, Loefflier JS (1994) Adaptation of the relocatable Gill-Thomas-Cosman frame in stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 30: 685–691PubMedGoogle Scholar
  64. Krol AD, Aussems P, Noordijk EM, Hermans J, Leer JW (1996) Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 34:297–302CrossRefPubMedGoogle Scholar
  65. Kupelian PA, Komaki R, Allen P (1996) Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 36:607–613CrossRefPubMedGoogle Scholar
  66. Kutcher GJ, Burman C (1987) Calculation of probability factors for non-uniform normal tissue irradiation: the effective volume method. Med Phys 14:487Google Scholar
  67. Kwa SL, Theuws JC, Wagenaar A, Damen EM, Boersma LJ, Baas P, Muller SH, Lebesque JV (1998) Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 48:61–69CrossRefPubMedGoogle Scholar
  68. Lagerwaard FJ, Senan S, van Meerbeeck JP, Graveland WJ (2002) Has 3-D conformal radiotherapy (3D-CRT) improved local tumour control for stage I non-small cell lung cancer? Radiother Oncol 63:151–157CrossRefPubMedGoogle Scholar
  69. Langendijk JA, Aaronson NK, ten Velde GPM, de Jong JM, Muller MJ, Wouters EF (2000) Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy. Acta Oncol 39:949–958CrossRefPubMedGoogle Scholar
  70. Lee JS, Scott C, Komaki R, Fossella FV, Dundas GS, McDonald S, Byhardt RW, Curran WJ Jr (1996) Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: Radiation Therapy Oncology Group protocol 91-06. J Clin Oncol 14:1055–1064PubMedGoogle Scholar
  71. Lee S, Choi EK, Park HJ, Ahn SD, Kim JH, Kim KJ, Yoon SM, Kim YS, Yi BY (2003) Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 40:309–315PubMedGoogle Scholar
  72. Lyman JT, Wolbarst AB (1987) Optimization of radiation therapy III. A method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 13:103–109PubMedGoogle Scholar
  73. MacManus MP, Hicks RJ, Matthews JP, Hogg A, McKenzie AF, Wirth A, Ware RE, Ball DL (2001) High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: implications for radical therapy. Int J Radiat Oncol Biol Phys 50:287–294CrossRefPubMedGoogle Scholar
  74. Maguire PD, Sibley GS, Zhou SM, Jamieson TA, Light KL, Antoine PA, Herndon JE 2nd, Anscher MS, Marks LB (1999) Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 45:97–103CrossRefPubMedGoogle Scholar
  75. Maguire PD, Marks LB, Sibley GS, Herndon JE 2nd, Clough RW, Light KL, Hernando ML, Antoine PA, Anscher MS (2001) 73.6 Gy and beyond: Hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer. J Clin Oncol 19:705–711PubMedGoogle Scholar
  76. Mah K, van Dyk J, Keane T, Poon PY (1987) Acute radiation-induced pulmonary damage: a clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys 13:179–188PubMedGoogle Scholar
  77. Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, Herndon JE, Patz EF Jr (1999) Staging non-small cell lung cancer with whole-body PET. Radiology 212:803–809PubMedGoogle Scholar
  78. Martel MK, Ten Haken RK, Hazuka MB, Turrisi AT, Fraass BA, Lichter AS (1994) Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28:575–581PubMedGoogle Scholar
  79. Martel MK, Sahijdak WM, Hayman JA (1999) Incidental dose to clinically negative nodes from conformal treatment fields for nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 45:244 (abstract)CrossRefGoogle Scholar
  80. Martini N, Beattie E (1977) Results of surgical treatment in stage I lung cancer. J Thorac Cardiovasc Surg 74:499–505PubMedGoogle Scholar
  81. Maruyama R, Sugio K, Mitsudomi T, Saitoh G, Ishida T, Sugimachi K (1997) Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 114:535–543CrossRefPubMedGoogle Scholar
  82. McDonald S, Rubin P, Phillips TL, Marks LB (1995) Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 31:1187–1203CrossRefPubMedGoogle Scholar
  83. McGarry RC, Song G, des Rosiers P, Timmermann R (2002) Observation-only management of early stage, medically inoperable lung cancer. Poor outcome. Chest 121:1155–1158CrossRefPubMedGoogle Scholar
  84. Mizushima Y, Noto H, Sugiyama S, Kusajima Y, Yamashita R, Kashii T, Kobayashi M (1997) Survival and prognosis after pneumonectomy for lung cancer in the elderly. Ann Thorac Surg 64:193–198CrossRefPubMedGoogle Scholar
  85. Morita K, Fuwa N, Suzuki Y, Nishio M, Sakai K, Tamaki Y, Niibe H, Chujo M, Wada S, Sugawara T, Kita M (1997) Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: retrospective analysis of 149 patients. Radiother Oncol 42:31–36CrossRefPubMedGoogle Scholar
  86. Morrison R, Delley TJ, Cleland WP (1963) The treatment of carcinoma of the bronchus. A clinical trial to compare surgery and supervoltage radiotherapy. Lancet 1:683–684CrossRefGoogle Scholar
  87. Moss WT, Haddy FJ, Sweany SK (1960) Some factors altering the severity of acute radiation pneumonitis: variation with cortisone, heparin, and antibiotica. Radiology 75:50–54PubMedGoogle Scholar
  88. Mountain CF (1986) A new international staging system for lung cancer. Chest 89:225S–233SPubMedGoogle Scholar
  89. Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717PubMedGoogle Scholar
  90. Movsas B, Scott C, Sause W, Byhardt R, Komaki R, Cox J, Johnson D, Lawton C, Dar AR, Wasserman T, Roach M, Lee JS, Andras JE (1999) The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): A quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) chemoradiation studies. Int J Radiat Oncol Biol Phys 45:1143–1149CrossRefPubMedGoogle Scholar
  91. Movsas B, Scott C, Sause W (2000) Age dramatically impacts on the quality-adjusted time without symptoms or toxicity (Q_Twist) in locally advanced non-small cell lung cancer (LA-NSCLC) — a radiation therapy oncology group (RTOG) analysis. Proc 42nd Ann Meet Am Soc Ther Radiol Oncol (abstract 92)Google Scholar
  92. Nagata Y, Negoro Y, Aoki T, Mizowaki T, Takayama K, Kokubo M, Araki N, Mitsumori M, Sasai K, Shibamoto Y, Koga S, Yano S, Hiraoka M (2002) Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52:1041–1046CrossRefPubMedGoogle Scholar
  93. Naruke T, Goya T, Tsuchiya R, Suemasu K (1988) Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96:440–447PubMedGoogle Scholar
  94. Noordijk EM, von der Poest Clement E, Hermans J, Wever AM, Leer JW (1988) Radiotherapy as an alternative to surgery in elderly patients with respectable lung cancer. Radiother Oncol 13:83–89PubMedGoogle Scholar
  95. Oetzel D, Schraube P, Hensley F, Sroka-Perez G, Menke M, Flentje M (1995) Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33:455–460CrossRefPubMedGoogle Scholar
  96. Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, Chang T-C, Fujita K, Oita M, Miyasaka K, Nishimura M, Dosaka-Akita H (2003) Tolerance of organs at riskin small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56:126–135CrossRefPubMedGoogle Scholar
  97. Ono R, Egawa S, Suemasu K, Sakura M, Kitagawa T (1991) Radiotherapy in inoperable stage I lung cancer. Jpn J Clin Oncol 21:125–128PubMedGoogle Scholar
  98. Passlick B, Izbicki JR, Kubuschok B, Thetter O, Pantel K (1996) Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg 61:177–183CrossRefPubMedGoogle Scholar
  99. Pastorino U, Andreola S, Tagliabue E, Pezzella F, Incarbone M, Sozzi G, Buyse M, Menard S, Pierotti M, Rilke F (1997) Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol 15:2858–2865PubMedGoogle Scholar
  100. Prasad SC (1978) Relation between tolerance dose and treatment field size in radiation therapy. Med Phys 5:430–433CrossRefPubMedGoogle Scholar
  101. Robertson JM, Ten Haken RK, Hazuka MB, Turrisi AT, Martel MK, Pu AT, Littles JF, Martinez FJ, Francis IR, Quint LE, Lichter AS (1997) Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 37:1079–1085CrossRefPubMedGoogle Scholar
  102. Rosenthal SA, Curran WJ Jr, Herbert SH, Hughes EN, Sandler HM, Stafford PM, McKenna WG (1992) Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (NI disease). Cancer 70:3410–3417Google Scholar
  103. Rosenzweig KE, Sim SE, Mychalczak B, Braban LE, Schindelheim R, Leibel SA (2001) Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50:681–685CrossRefPubMedGoogle Scholar
  104. Rubin P, Casarett GW (1968) Clinical radiation pathology. Saunders, Philadelphia, pp 423–470Google Scholar
  105. Sandler HM, Curran WJ Jr, Turrisi AT III (1990) The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 19:9–13PubMedGoogle Scholar
  106. Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Palmar M (1999) Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. Radiother Oncol 52:137–148CrossRefPubMedGoogle Scholar
  107. Saunders CA, Dussek JE, O'Doherty MJ, Maisey MN (1999) Evaluation of Fluorine-18-Fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg 76:790–797CrossRefGoogle Scholar
  108. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT (1995) Radiation Therapy Oncology Group 88-08 and Eastern Cooperative Oncology Group 4588: preliminary results of a phase III trial in regionally advanced, unresectable nons-mall cell lung cancer. J Natl Cancer Inst 87:198–205PubMedGoogle Scholar
  109. Sawyer TE, Bonner JA, Gould PM, Deschamps C, Lange CM, Li H (1999) Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer. Implications in the inoperable and three-dimensional dose-escalation settings. Int J Radiat Oncol Biol Phys 43:965–970CrossRefPubMedGoogle Scholar
  110. Senan S, Burgers S, Samson MJ, van Klaveren RJ, Oei SS, van Sornsen de Koste J, Voet PW, Lagerwaard FJ, Maarten van Haarst J, Aerts JG, van Meerbeeck JP (2002) Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 54:999–1006CrossRefPubMedGoogle Scholar
  111. Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR (1998) Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 40:149–154CrossRefPubMedGoogle Scholar
  112. Slebos RJ, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJ, Wagenaar SS, Vanderschueren RG, van Zandwijk N, Mooi WJ (1990) K-ras oncogene activation as prognostic marker in adenocarcinoma of lung. N Engl J Med 323:561–566PubMedGoogle Scholar
  113. Slotman BJ, Karim ABMF (1994) Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 29:33–37PubMedGoogle Scholar
  114. Slotman BJ, Antonisse IE, Njo KH (1996) Limited field irradiation in early stage (T1–2 N0) non-small cell lung cancer. Radiother Oncol 41:41–44PubMedGoogle Scholar
  115. Smart J (1966) Can lung cancer be cured by irradiation alone? JAMA 195:1034–1035CrossRefPubMedGoogle Scholar
  116. Sturm V, Kober H, Hover K-H, Schlegel W, Boesecke R, Pastyr O, Hartmann GH, Schabbert S, zum Winkel K, Kunze S (1987) Stereotactic percutaneous single dose irradiation of brain metastasis with a linear accelerator. Int J Radiat Oncol Biol Phys 13:279–282PubMedGoogle Scholar
  117. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Nishiwaki Y (1999) Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg 117:593–598PubMedGoogle Scholar
  118. Suzuki K, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y (2001) Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg 72:352–356CrossRefPubMedGoogle Scholar
  119. Takizawa T, Terashima M, Koike T, Watanabe T, Kurita Y, Yokoyama A, Honma K (1998) Lymph node metastasis in small peripheral adenocarcinoma of the lung. J Thorac Cardiovasc Surg 116:276–280PubMedGoogle Scholar
  120. Talton BM, Constable WC, Kersh CR (1990) Curative radiotherapy for technically operable Stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 19:15–21PubMedGoogle Scholar
  121. Tateishi M, Ishida T, Mitsudomi, Kaneko S, Sugimachi K (1991) Prognostic value of c-erB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer 27:1372–1375PubMedGoogle Scholar
  122. Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, Williams M (2003) Extracranial stereotactic radioablation. Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 123:1946–1955CrossRefGoogle Scholar
  123. Uematsu M, Shioda A, Tahara K, Fukui T, Yamamoto F, Tsumatori G, Ozeki Y, Aoki T, Watanabe M, Kusano S (1998) Focal, high-dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients. A preliminary experience. Cancer 82:1062–1070CrossRefPubMedGoogle Scholar
  124. Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, Wong JR, Kusano S (2001) Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: a year experience. Int J Radiat Oncol Biol Phys 51:666–670CrossRefPubMedGoogle Scholar
  125. Varlotto JM, Shieeve DC, Alexander E III, Kooy HM, Black PM, Loeffler JS (1996) Fractionated stereotactic radiotherapy for the treatment of acoustic neuromas: preliminary results. Int J Radiat Oncol Biol Phys 36:141–145CrossRefPubMedGoogle Scholar
  126. Whittle J, Steinberg EP, Anderson G, Herbert R (1991) Use of Medicare claims data to evaluate outcomes in elderly patients undergoing lung resection for lung cancer. Chest 100:729–734PubMedGoogle Scholar
  127. Whyte RI, Crownover R, Murphy MJ, Martin DP, Rice TW, DeCamp M Jr, Rodebaugh R, Weinhous MS, Le Q-T (2003) Stereotactic radiosurgery for lung tumors: preliminary results of a phase I trial. Ann Thorac Surg 75:1097–1101CrossRefPubMedGoogle Scholar
  128. Williams TE, Thomas CR Jr, Turrisi AT III (2000) Better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. Semin Rad Oncol 10:315–323Google Scholar
  129. Wu J, Ohta Y, Minato H, Tsunezuka Y, Oda M, Watanabe Y, Watanabe G (2001) Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less I ndiameter. Ann Thorac Surg 71:1772–1777CrossRefPubMedGoogle Scholar
  130. Zhang HX, Yin WB, Zhang LJ, Yang ZY, Zhang ZX, Wang M, Chen DF, Gu XZ (1989) Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol 14:89–94CrossRefPubMedGoogle Scholar
  131. Zierhut D, Bettscheider C, Schubert K, van Kampen M, Wannenmacher M (2001) Radiation therapy of stage I and II non-small cell lung cancer (NSCLC). Lung Cancer 34[Suppl 3]:S39–43CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Branislav Jeremić
    • 1
  1. 1.Department of Radiation Oncology, Klinikum rechts der IsarTechnische Universität MünchenMunichGermany

Personalised recommendations